Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Heightens Visibility via Nasdaq Listing

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, recently announced its uplisting to the Nasdaq Capital Market and rang the opening bell on Friday, Feb. 28, 2020.  An article discussing the company reads, “‘We’ve been under the radar for a long time. We’re trying to create visibility among the investor base by doing the right thing,’ CEO Suren Ajjarapu stated late last year following completion of an agreement between its subsidiary Bonum Health and Benzer Pharmacy to create a network of ‘Bonum Health Hub’ units in small towns and rural areas as part of the lead-up to the Nasdaq listing ( . . . The company recently completed a firm-commitment public offering of 806,452 shares of its common stock following a voter-approved reverse stock split. Trxade expects to gain gross proceeds of $5.2 million from the sale of common stock in the offering, minus standard expenses tied to the offering.”

To view the full article, visit

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group Inc. (NASDAQ: MEDS) is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the Trxade B2B trading platform with 11,900 registered pharmacies; and licensed virtual wholesale and mail-order pharmacy-delivery capabilities using DelivMeds app. For additional information, please visit, and

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS). Bookmark the permalink.

Comments are closed.